|
CCT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.459600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.195370E-01 |
| Normal-vs-Stage2 |
6.796800E-01 |
| Normal-vs-Stage3 |
8.635900E-03 |
| Normal-vs-Stage4 |
5.670500E-02 |
| Stage1-vs-Stage2 |
7.190200E-01 |
| Stage1-vs-Stage3 |
3.643800E-02 |
| Stage1-vs-Stage4 |
1.115630E-01 |
| Stage2-vs-Stage3 |
8.209600E-02 |
| Stage2-vs-Stage4 |
1.010980E-01 |
| Stage3-vs-Stage4 |
8.720400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.422300E-03 |
| Normal-vs-AfricanAmerican |
2.156300E-02 |
| Normal-vs-Asian |
5.075200E-01 |
| Caucasian-vs-AfricanAmerican |
7.012800E-01 |
| Caucasian-vs-Asian |
8.044200E-01 |
| AfricanAmerican-vs-Asian |
8.980400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.638400E-02 |
| Normal-vs-Female |
8.392500E-04 |
| Male-vs-Female |
1.459560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.243800E-01 |
| Normal-vs-Extreme_Weight |
4.383400E-01 |
| Normal-vs-Obese |
3.154400E-02 |
| Normal-vs-Extreme_Obese |
8.466400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.366200E-01 |
| Normal_Weight-vs-Obese |
5.355400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.441400E-01 |
| Extreme_Weight-vs-Obese |
1.531380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.110800E-01 |
| Obese-vs-Extreme_Obese |
2.692400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.020900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.164800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.167210E-01 |
| Normal-vs-Age(81-100Yrs) |
5.016800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.570190E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.176500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.814500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.191600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.122600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.310200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.263600E-02 |
| Normal-VS-Type2 PRCC |
5.398100E-02 |
| Normal-VS-KIRP CIMP |
5.360400E-02 |
| Normal-VS-Unclassified PRCC |
1.116550E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.618800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.193780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.896800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.683800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.774800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.375600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.359200E-01 |
| Normal-vs-N1 |
1.830570E-04 |
| Normal-vs-N2 |
2.450600E-01 |
| N0-vs-N1 |
4.645400E-04 |
| N0-vs-N2 |
5.171000E-01 |
| N1-vs-N2 |
3.952500E-02 |
|
|
